Percutaneous Transcatheter Implantation of an Aortic Valve Prosthesis for Calcific Aortic Stenosis: First Human Case Description
By A. Cribier, H. Eltchaninoff, Assaf Bash, N. Borenstein, C. Tron, F. Bauer, G. Derumeaux, F. Anselme, F. Laborde, M. Leon. Circulation, 2002
3,214 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology
View Paper: https://www.semanticscholar.org/paper/fd38a832ac8a4fc2b830b53f8f6d48091cea6b90
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Epidemiology
Citations in the corpus
- SCCT expert consensus document on computed tomography imaging before transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). (2012, methodology): “In 2002, the first catheter-based aortic valve implantation was performed in a human.(4) In the past years, this procedure has become increasingly common and is an accepted alternative to surgical aortic valve replacement in patients with contraindications to surgery or high surgical risk.”
- Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. (2011, methodology): “The first implant in man was performed by Cribier (5) in 2002, using a balloon expandable frame and equine valve.”
- 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. (2012, methodology): “This initial seminal experience was followed in 2002 by the first human TAVR using the antegrade approach to implant a balloon expandable equine pericardial leaflet stent valve (93).”
- Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. (2006, methodology): “Though previous attempts at percutaneous alve replacement in the aortic position had been limited by the pplicability to humans (5,6), this percutaneous heart valve PHV) was successfully implanted on April 16, 2002, in a atient with inoperable aortic stenosis and life-threatening omorbidities (7).”
- Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. (2011, background): “T ince the introduction of transcatheter aortic valve implanation (TAVI) in 2002 (1), there has been increasing nterest in the field of catheter-based treatment of highurgical-risk patients with symptomatic aortic stenosis (AS)”